Cipla's New CEO To Focus On Innovation, In-Licensing, With Eye On Africa
This article was originally published in PharmAsia News
Executive Summary
Two months into the job, Cipla CEO Subhanu Saxena says India's second-largest maker of generic drugs will focus on innovation and in-licensing in Australia, Europe and the U.S., a switch from the past.